openPR Logo
Press release

Investigation announced for Long-Term Investors in CareDx, Inc (NASDAQ: CDNA) over potential Wrongdoing

09-13-2022 08:41 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in CareDx, Inc (NASDAQ: CDNA) shares.

An investigation on behalf of current long term investors in CareDx, Inc (NASDAQ: CDNA) shares.

An investigation was announced for current long-term investors in shares of CareDx, Inc (NASDAQ: CDNA) concerning potential breaches of fiduciary duties by certain directors and officers of CareDx, Inc.

Investors who are current long term investors in CareDx, Inc (NASDAQ: CDNA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: CDNA stocks follows a lawsuit filed against CareDx, Inc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CDNA stocks, concerns whether certain CareDx directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that the Defendants misled investors and/or failed to disclose that Defendants had engaged in a variety of improper and illegal schemes to inflate testing services revenue and demand, including pushing a surveillance protocol through inaccurate marketing materials, offering extravagant inducements or kickbacks to physicians and other providers, and improperly bundling expensive testing services with other blood tests as part of the RemoTraC service, that these practices, and others, subjected CareDx to an undisclosed risk of regulatory scrutiny, that these practices rendered the Company's testing services revenue reported between February 24, 2021 and May 5, 2022 artificially inflated, and that as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of CareDx, Inc (NASDAQ: CDNA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in CareDx, Inc (NASDAQ: CDNA) over potential Wrongdoing here

News-ID: 2733469 • Views: 367

More Releases from Shareholders Foundation

Investigation announced for Investors who lost Money with their shares in Roblox …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Roblox Corporation. Investors who purchased shares of Roblox Corporation (NYSE: RBLX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Roblox directors breached their fiduciary duties and caused damage to the company and its shareholders. San Mateo, CA based Roblox Corporation develops
Investigation announced for Investors in Waterdrop Inc. (NYSE: WDH) over possibl …
An investigation was announced over potential securities laws violations by Waterdrop Inc. in connection with certain financial statements. Investors who purchased shares of Waterdrop Inc. (NYSE: WDH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Waterdrop Inc. (NYSE: WDH regarding its business, its prospects and its operations were materially
Sinovac Biotech Ltd. (formerly NASDAQ: SVA) Investor Notice: Deadline in Lawsuit …
A deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) over alleged securities laws violations by Sinovac Biotech Ltd. Investors who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) have certain options and there are strict and short deadlines running. Deadline: October 17, 2022. Sinovac Biotech Ltd. (formerly NASDAQ: SVA) stockholders should contact the Shareholders Foundation at
Investigation announced for Investors in Anaplan, Inc. (NYSE: PLAN) over potenti …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Anaplan, Inc. Investors who are current long term investors in Anaplan, Inc. (NYSE: PLAN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: PLAN stocks follows a lawsuit filed against Anaplan, Inc. over

All 5 Releases